{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T08:53:39Z","timestamp":1776934419682,"version":"3.51.2"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,4,12]],"date-time":"2024-04-12T00:00:00Z","timestamp":1712880000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,4,12]],"date-time":"2024-04-12T00:00:00Z","timestamp":1712880000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Digit. Med."],"DOI":"10.1038\/s41746-024-01098-5","type":"journal-article","created":{"date-parts":[[2024,4,12]],"date-time":"2024-04-12T14:01:53Z","timestamp":1712930513000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Navigating the U.S. regulatory landscape for neurologic digital health technologies"],"prefix":"10.1038","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4603-4586","authenticated-orcid":false,"given":"Neil A.","family":"Busis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dilshad","family":"Marolia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Montgomery","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura J.","family":"Balcer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven L.","family":"Galetta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott N.","family":"Grossman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,4,12]]},"reference":[{"key":"1098_CR1","unstructured":"U.S. Food & Drug Administration (FDA). Digital health technologies for remote data acquisition in clinical investigations. https:\/\/www.fda.gov\/media\/155022\/download (2021)."},{"key":"1098_CR2","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/nrneurol.2018.31","volume":"14","author":"ER Dorsey","year":"2018","unstructured":"Dorsey, E. R., Glidden, A. M., Holloway, M. R., Birbeck, G. L. & Schwamm, L. H. Teleneurology and mobile technologies: the future of neurological care. Nat. Rev. Neurol. 14, 285\u2013297 (2018).","journal-title":"Nat. Rev. Neurol."},{"key":"1098_CR3","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1055\/s-0041-1741495","volume":"42","author":"AS Gupta","year":"2022","unstructured":"Gupta, A. S. Digital phenotyping in clinical neurology. Semin. Neurol. 42, 48\u201359 (2022).","journal-title":"Semin. Neurol."},{"key":"1098_CR4","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/s41746-023-00767-1","volume":"6","author":"L Masanneck","year":"2023","unstructured":"Masanneck, L., Gieseler, P., Gordon, W. J., Meuth, S. G. & Stern, A. D. Evidence from ClinicalTrials.gov on the growth of digital health technologies in neurology trials. NPJ Digit. Med. 6, 23 (2023).","journal-title":"NPJ Digit. Med."},{"key":"1098_CR5","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1038\/s41531-023-00581-2","volume":"9","author":"C Sotirakis","year":"2023","unstructured":"Sotirakis, C. et al. Identification of motor progression in Parkinson\u2019s disease using wearable sensors and machine learning. NPJ Parkinsons Dis. 9, 142 (2023).","journal-title":"NPJ Parkinsons Dis."},{"key":"1098_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2024.1310548","volume":"15","author":"AS Nunes","year":"2024","unstructured":"Nunes, A. S. et al. Digital assessment of speech in Huntington disease. Front. Neurol. 15, 1310548 (2024).","journal-title":"Front. Neurol."},{"key":"1098_CR7","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.123.044251","author":"LH Schwamm","year":"2024","unstructured":"Schwamm, L. H. Reimagining stroke quality of care in the age of artificial intelligence and digital enablement. Stroke https:\/\/doi.org\/10.1161\/STROKEAHA.123.044251 (2024).","journal-title":"Stroke"},{"key":"1098_CR8","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1056\/NEJMra2301913","volume":"390","author":"E Donner","year":"2024","unstructured":"Donner, E., Devinsky, O. & Friedman, D. Wearable digital health technology for epilepsy. N. Engl. J. Med. 390, 736\u2013745 (2024).","journal-title":"N. Engl. J. Med."},{"key":"1098_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2022.120150","volume":"434","author":"G Park","year":"2022","unstructured":"Park, G. et al. The MICK (Mobile integrated cognitive kit) app: digital rapid automatized naming for visual assessment across the spectrum of neurological disorders. J. Neurol. Sci. 434, 120150 (2022).","journal-title":"J. Neurol. Sci."},{"key":"1098_CR10","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1212\/WNL.0000000000013200","volume":"98","author":"DT Jones","year":"2022","unstructured":"Jones, D. T. & Kerber, K. A. Artificial intelligence and the practice of neurology in 2035: the neurology future forecasting series. Neurology 98, 238\u2013245 (2022).","journal-title":"Neurology"},{"key":"1098_CR11","unstructured":"Digital Medicine Society. Digital Health Product Categorization Guide. https:\/\/dimesociety.org\/wp-content\/uploads\/Digital-Health-Product-Categorization-Guide_DiMe_RegPath.pdf (2023)."},{"key":"1098_CR12","unstructured":"U.S. Food & Drug Administration (FDA). Digital Health Center of Excellence. https:\/\/www.fda.gov\/digitalhealth (2024)."},{"key":"1098_CR13","unstructured":"U.S. Food & Drug Administration (FDA). Medical Devices Advisory Committee. https:\/\/www.fda.gov\/advisory-committees\/medical-devices\/medical-devices-advisory-committee (2019)."},{"key":"1098_CR14","unstructured":"U.S. Food & Drug Administration (FDA). Step 5: FDA post-market device safety monitoring. https:\/\/www.fda.gov\/patients\/device-development-process\/step-5-fda-post-market-device-safety-monitoring (2018)."},{"key":"1098_CR15","unstructured":"U.S. Food & Drug Administration (FDA). Devices@FDA. https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/devicesatfda\/index.cfm (2023)."},{"key":"1098_CR16","unstructured":"U.S. Food & Drug Administration (FDA). Product Classification. https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfPCD\/classification.cfm (2023)."},{"key":"1098_CR17","unstructured":"U.S. Food & Drug Administration (FDA). Clinical decision support software - Guidance for industry and food and drug administration staff. https:\/\/www.fda.gov\/media\/109618\/download (2022)."},{"key":"1098_CR18","unstructured":"U.S. Food & Drug Administration (FDA). Medical device safety and the 510(k) clearance process. https:\/\/www.fda.gov\/medical-devices\/510k-clearances\/medical-device-safety-and-510k-clearance-process (2023)."},{"key":"1098_CR19","unstructured":"U.S. Food & Drug Administration (FDA). Do not use smartwatches or smart rings to measure blood glucose levels: FDA safety communication. https:\/\/www.fda.gov\/medical-devices\/safety-communications\/do-not-use-smartwatches-or-smart-rings-measure-blood-glucose-levels-fda-safety-communication (2024)."},{"key":"1098_CR20","unstructured":"U.S. Food & Drug Administration (FDA). Collaborative communities: addressing health care challenges together. https:\/\/www.fda.gov\/about-fda\/cdrh-strategic-priorities-and-updates\/collaborative-communities-addressing-health-care-challenges-together (2024)."},{"key":"1098_CR21","doi-asserted-by":"publisher","first-page":"e200","DOI":"10.1016\/S2589-7500(21)00292-2","volume":"4","author":"A Stern","year":"2022","unstructured":"Stern, A. et al. Advancing digital health applications: priorities for innovation in real-world evidence generation. Lancet Digit. Health 4, e200\u2013e206 (2022).","journal-title":"Lancet Digit. Health"},{"key":"1098_CR22","unstructured":"American Medical Association. Driving the future of digital health. https:\/\/www.ama-assn.org\/practice-management\/digital\/driving-future-digital-health (2024)."},{"key":"1098_CR23","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/s41746-022-00723-5","volume":"5","author":"RA Frank","year":"2022","unstructured":"Frank, R. A. et al. Developing current procedural terminology codes that describe the work performed by machines. NPJ Digit. Med. 5, 177 (2022).","journal-title":"NPJ Digit. Med."},{"key":"1098_CR24","unstructured":"American Medical Association (AMA). Current Procedural Terminology (CPT\u00ae) 2024. (American Medical Association, 2023)."},{"key":"1098_CR25","unstructured":"Centers for Medicare & Medicaid Services (CMS). Physician fee schedule. https:\/\/www.cms.gov\/medicare\/payment\/fee-schedules\/physician (2023)."},{"key":"1098_CR26","unstructured":"American Medical Association (AMA). RVS update committee (RUC). https:\/\/www.ama-assn.org\/about\/rvs-update-committee-ruc\/rvs-update-committee-ruc (2023)."},{"key":"1098_CR27","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1159\/000509725","volume":"3","author":"C Manta","year":"2020","unstructured":"Manta, C., Patrick-Lake, B. & Goldsack, J. C. Digital measures that matter to patients: a framework to guide the selection and development of digital measures of health. Digit Biomark. 3, 69\u201377 (2020).","journal-title":"Digit Biomark."},{"key":"1098_CR28","doi-asserted-by":"publisher","first-page":"e2321792","DOI":"10.1001\/jamanetworkopen.2023.21792","volume":"6","author":"P Clark","year":"2023","unstructured":"Clark, P., Kim, J. & Aphinyanaphongs, Y. Marketing and US Food and Drug Administration clearance of artificial intelligence and machine learning enabled software in and as medical devices: A systematic review. JAMA Netw. Open 6, e2321792 (2023).","journal-title":"JAMA Netw. Open"},{"key":"1098_CR29","doi-asserted-by":"publisher","first-page":"e2321753","DOI":"10.1001\/jamanetworkopen.2023.21753","volume":"6","author":"NH Shah","year":"2023","unstructured":"Shah, N. H. & Mello, M. M. Discrepancies between clearance summaries and marketing materials of software-enabled medical devices cleared by the US Food and Drug Administration. JAMA Netw. Open 6, e2321753 (2023).","journal-title":"JAMA Netw. Open"},{"key":"1098_CR30","unstructured":"American Medical Association (AMA). Future of health issue brief: commercial payer coverage for digital medicine codes. https:\/\/www.ama-assn.org\/system\/files\/issue-brief-commercial-payer-coverage-digital-care.pdf (2023)."},{"key":"1098_CR31","unstructured":"U.S. Food & Drug Administration (FDA). De novo classification request for EyeBOX. https:\/\/www.accessdata.fda.gov\/cdrh_docs\/reviews\/DEN170091.pdf (2017)."},{"key":"1098_CR32","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1080\/02699052.2017.1374469","volume":"32","author":"J Raynowska","year":"2018","unstructured":"Raynowska, J. et al. Validity of low-resolution eye-tracking to assess eye movements during a rapid number naming task: performance of the eyetribe eye tracker. Brain Inj. 32, 200\u2013208 (2018). Epub 2017 Dec 6.","journal-title":"Brain Inj."},{"key":"1098_CR33","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1097\/WNO.0000000000000726","volume":"39","author":"O Akhand","year":"2019","unstructured":"Akhand, O. et al. History and future directions of vision testing in head trauma. J. Neuroophthalmol. 39, 68\u201381 (2019).","journal-title":"J. Neuroophthalmol."},{"key":"1098_CR34","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.jns.2016.10.044","volume":"372","author":"L Cobbs","year":"2017","unstructured":"Cobbs, L. et al. Mobile Universal Lexicon Evaluation System (MULES) test: a new measure of rapid picture naming for concussion. J. Neurol. Sci. 372, 393\u2013398 (2017).","journal-title":"J. Neurol. Sci."},{"key":"1098_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2022.120445","volume":"442","author":"CA Bell","year":"2022","unstructured":"Bell, C. A. et al. MICK (Mobile Integrated Cognitive Kit) app: feasibility of an accessible tablet-based rapid picture and number naming task for concussion assessment in a division 1 college football cohort. J. Neurol. Sci. 442, 120445 (2022).","journal-title":"J. Neurol. Sci."},{"key":"1098_CR36","unstructured":"U.S. Food & Drug Administration (FDA). Framework for the use of digital health technologies in drug and biological product development. https:\/\/www.fda.gov\/media\/166396\/download (2023)."},{"key":"1098_CR37","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/s41746-023-00836-5","volume":"6","author":"J Silberman","year":"2023","unstructured":"Silberman, J. et al. Rigorous and rapid evidence assessment in digital health with the evidence DEFINED framework. NPJ Digit. Med. 6, 101 (2023).","journal-title":"NPJ Digit. Med."},{"key":"1098_CR38","unstructured":"U.S. Food & Drug Administration (FDA). Medical device safety action plan: protecting patients, promoting public health. https:\/\/www.fda.gov\/files\/about%20fda\/published\/Medical-Device-Safety-Action-Plan--Protecting-Patients--Promoting-Public-Health-%28PDF%29.pdf (2018)."},{"key":"1098_CR39","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1038\/s41746-022-00621-w","volume":"5","author":"MD Abramoff","year":"2022","unstructured":"Abramoff, M. D. et al. A reimbursement framework for artificial intelligence in healthcare. NPJ Digit. Med. 5, 72 (2022).","journal-title":"NPJ Digit. Med."},{"key":"1098_CR40","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.7326\/M23-1182","volume":"176","author":"M Tang","year":"2023","unstructured":"Tang, M. et al. Effects of remote patient monitoring use on care outcomes among medicare patients with hypertension : an observational study. Ann. Intern. Med. 176, 1465\u20131475 (2023).","journal-title":"Ann. Intern. Med."},{"key":"1098_CR41","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1038\/s41582-023-00830-1","volume":"19","author":"E Moro","year":"2023","unstructured":"Moro, E. How can we stop digital technologies from worsening existing health inequalities? Nat. Rev. Neurol. 19, 449\u2013450 (2023).","journal-title":"Nat. Rev. Neurol."},{"key":"1098_CR42","unstructured":"Peterson Health Technology Institute. Digital health collaborative. https:\/\/phti.com\/digital-health-collaborative\/ (2024)."},{"key":"1098_CR43","unstructured":"U.S. Food & Drug Administration (FDA). FDA establishes new advisory committee on digital health technologies. https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-establishes-new-advisory-committee-digital-health-technologies (2023)."}],"container-title":["npj Digital Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41746-024-01098-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41746-024-01098-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41746-024-01098-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,12]],"date-time":"2024-04-12T14:07:14Z","timestamp":1712930834000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41746-024-01098-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,12]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1098"],"URL":"https:\/\/doi.org\/10.1038\/s41746-024-01098-5","relation":{},"ISSN":["2398-6352"],"issn-type":[{"value":"2398-6352","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,12]]},"assertion":[{"value":"6 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"N.A.B. has received personal compensation for serving as CPT\u00ae advisor for the American Academy of Neurology (AAN) and for AAN speaking engagements but declares no non-financial competing interests. L.J.B. is editor-in-chief of the Journal of Neuro-Ophthalmology but declares no non-financial competing interests. D.M., R.M., S.L.G. and S.N.G. declare no financial or non-financial competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"94"}}